Occupational Exposures Linked to Interstitial Lung Disease

This article originally appeared here.
Share this content:
Occupational Exposures Linked to Interstitial Lung Disease
Occupational Exposures Linked to Interstitial Lung Disease

MONDAY, Aug. 7, 2017 (HealthDay News) -- Occupational exposures to vapors, gas, dust, and fumes (VGDF) are associated with high attenuation areas (HAA) and interstitial lung abnormalities (ILA), according to a study published online July 28 in the American Journal of Respiratory and Critical Care Medicine.

Coralynn S. Sack, M.D., from the University of Washington in Seattle, and colleagues performed analyses of participants enrolled in the population-based Multi-Ethnic Study of Atherosclerosis. At baseline and on serial cardiac computed tomography (CT) scans, HAA was measured in 5,702 participants. In a subset of 2,312 participants who underwent full lung CT scanning at 10-year follow-up, ILA was ascertained.

The researchers found that each job exposure matrix (JEM) score increment in exposure to VGDF correlated with an approximately 3 percent increase in HAA. Among those currently employed and those younger than 65 years old, self-reported vapors/gas exposure correlated with increased odds of ILA (1.76-, and 1.97-fold, respectively). No consistent evidence was seen for the correlation of occupational exposures with HAA progression over the follow-up period.

"JEM-assigned and self-reported exposures to VGDF were associated with measurements of subclinical interstitial lung disease in community-dwelling adults," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Even Overdose Doesn't Stop Opioid Prescribing

Even Overdose Doesn't Stop Opioid Prescribing

Few receive medication-assisted treatment after hospital discharge, researchers find

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

No improvement in clinical outcomes versus usual care in heart failure and reduced ejection fraction

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic Adults

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic ...

No decrease in cough duration, severity for adults without asthma with lower respiratory tract symptom

is free, fast, and customized just for you!

Already a member?

Sign In Now »